M Hingorani, WP Colley, S Dixit… - The British Journal of …, 2012 - ncbi.nlm.nih.gov
The prognosis of patients with glioblastoma (GBM) remains poor, and the use of
hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit …